Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2018-01-17 | 2018-07-23 | 36295 |
APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-08-12 | 2020-09-01 | 122065 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221084 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221102 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2021-04-23 | 2021-05-17 | 137959 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2025-02-13 | 2025-03-21 | 250316 |
APO-KETOROLAC INJECTABLE | 30MG | SOLUTION | Actual shortage | 2017-08-16 | 2017-10-05 | 19595 |
APO-KETOTIFEN - SYR 1MG/5ML | 1MG | SYRUP | Actual shortage | 2017-08-13 | 2017-10-05 | 19024 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-07-13 | 2023-07-21 | 198511 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-11-10 | 2024-01-05 | 209964 |
APO-LABETALOL | 100MG | TABLET | Resolved | 2023-12-01 | 2024-01-05 | 212359 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185489 |
APO-LABETALOL | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-21 | 195069 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2024-06-20 | 2024-06-28 | 231030 |
APO-LABETALOL | 100MG | TABLET | Resolved | 2024-09-27 | 2024-10-25 | 238826 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2024-09-27 | 2024-11-29 | 238829 |
APO-LABETALOL | 100MG | TABLET | Resolved | 2022-09-30 | 2022-10-14 | 170804 |
APO-LABETALOL TABLETS | 100MG | TABLET | Resolved | 2017-08-13 | 2021-01-11 | 19105 |
APO-LABETALOL TABLETS | 200MG | TABLET | Resolved | 2017-08-13 | 2021-01-11 | 19108 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |